Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Product: Visipaque. Active Ingredient(s): Iodixanol 305 mg/mL. Dosage Form: Solution for injection. NZ Sponsor: Nycomed New Zealand Limited. Manufacturer(s): Nycomed AS Production, Oslo, Norway. Nycomed Ireland Limited, Carrigtohil, Co. Cork, Eire. Product: Visipaque. Active Ingredient(s): Iodixanol 550 mg/mL. Dosage Form: Solution for injection. NZ Sponsor: Nycomed New Zealand Limited. Manufacturer(s): Nycomed AS Production, Oslo, Norway. Nycomed Ireland Limited, Carrigtohil, Co. Cork, Eire. Nycomed Puerto Rico Inc, Barceloneta, Puerto Rico. Product: Visipaque. Active Ingredient(s): Iodixanol 652 mg/mL. Dosage Form: Solution for injection. NZ Sponsor: Nycomed New Zealand Limited. Manufacturer(s): Nycomed AS Production, Oslo, Norway. Nycomed Ireland Limited, Carrigtohil, Co. Cork, Eire. Nycomed Puerto Rico Inc, Barceloneta, Puerto Rico. Dated this 22nd day of October 1999. S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).